Solomon Moshkevich

In this engaging discussion, Solomon Moshkevich, President of Clinical Diagnostics at Natera, delves into the power of molecular data in reshaping healthcare. He highlights how MRD testing and AI tools are revolutionizing clinical decisions in oncology and chronic kidney disease. Solomon shares insights on the innovative Signatera test for personalized care and addresses the challenges of integrating precision tools within health systems. He also discusses the promising future of early cancer screening and how genetics can transform chronic kidney disease management.